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Abstract
Background: Occludin is a tetraspanin protein normally localized to tight junctions. The protein
interacts with a variety of pathogens including viruses and bacteria, an interaction that sometimes
leads to its extrajunctional localization.
Results: Here we report that treatment of mammary epithelial monolayers with a circularized
peptide containing a four amino acid sequence found in the second extracellular loop of occludin,
LHYH, leads to the appearance of extrajunctional occludin and activation of the extrinsic apoptotic
pathway. At early times after peptide treatment endogenous occludin and the LYHY peptide were
co-localized in extrajunctional patches, which were also shown to contain components of the death
inducing signaling complex (DISC), caspases 8 and 3, the death receptor FAS and the adaptor
molecule FADD. After this treatment occludin could be immunoprecipitated with FADD,
confirming its interaction with the DISC. Extrusion after LYHY treatment was accomplished with
no loss of epithelial resistance.
Conclusion: These observations provide strong evidence that, following disruption, occludin
forms a complex with the extrinsic death receptor leading to extrusion of apoptotic cells from the
epithelial monolayer. They suggest that occludin has a protective as well as a barrier forming role
in epithelia; pathogenic agents which utilize this protein as an entry point into the cell might set off
an apoptotic reaction allowing extrusion of the infected cell before the pathogen can gain entry to
the interstitial space.
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Background
Tight junctions, known as the zonula occludens, form an
anastomosing network of protein and lipid strands that
apically circumscribe every luminal cell of an epithelium.
Classically, they form a continuous and selective barrier to
paracellular solute flux and ionic current (the gate func-
tion) and help maintain the distinct lipid and protein
composition of the apical and basolateral cellular mem-
branes (the fence function). It is becoming increasingly
clear that this structure is also the direct or indirect target
of many pathogens including Hepatitis C virus [1], Cox-
sackie virus [2,3], Clostridium perfringens endotoxin [4],
enteropathogenic E. coli [5,6], Campylobacter jejuni [7] and
others [8] and that the tight junction protein occludin is
often involved in host-pathogen interactions that result in
infection.
The tight junction is a complex and multifunctional struc-
ture consisting of integral membrane molecules, occludin,
claudins and junction adhesion molecule. Occludin and
the claudins are tetraspanin proteins with two extracellu-
lar loops and are considered to form the variable permea-
bility barrier between the luminal and interstitial spaces
separated by the epithelium. Tight junction plaque pro-
teins such as ZO1, ZO2, and ZO3 [8] link the integral pro-
teins to the actin cytoskeleton. They also interact with a
diverse group of signaling molecules that connect tight
junction function to paracellular permeability, cell divi-
sion, cell polarity and tumorigenesis [8,9]. The focus of
this paper, occludin, is a tetraspanin protein with four
transmembrane domains, intracellular N and C termini
and two extracellular loops (see Figure 1). Although
occludin has been shown to be important in establishing
and maintaining the physiological properties of the tight
junction [10,11], and appears to be important for survival
of cultured hepatocytes [12], the occludin-null mouse is
viable and appears to have relatively minor alterations in
epithelial function [13]. The claudins are now considered
to play the major role in tight junction formation and
adhesion [14]. Importantly for this work, interference
with occludin either by overexpression of a truncated
form [15] or with peptides that disrupt its cell recognition
complex [16-18] has been shown to alter endothelial or
epithelial permeability. More recently enteropathogenic
E. coli have been shown to alter occludin localization in
T84 epithelial cells and to bring about caspase mediated
apoptosis [6]. Intriguingly, overexpression of occludin in
a variety of tumor cells sensitized the cells to apoptosis
inducing agents [19] and occludin negative clones
showed reduced ability to extrude apoptotic cells from
MDCK monolayers [20]. Thus there is conflicting evi-
dence suggesting that occludin both enhances cell survival
[12,20] and participates in reactions leading to apoptosis
[6,19]. The work presented here suggests that occludin can
have an important direct interaction with the extrinsic
apoptotic pathway in the mammary epithelium.
Turnover of epithelial cells is a normal part of the differ-
entiated function of the simple epithelia that line most
mucosal surfaces; it has been best studied in the intestine
and mammary gland. The intestinal monolayer is in a
constant state of flux with cells originating in the crypt
moving to the apex of the microvillus where they undergo
apoptosis without a loss of epithelial integrity [21-23]. In
the mammary gland a massive wave of apoptosis in the
involuting gland leads to loss of 75% of the epithelial cells
within 3 days [24,25] with no apparent loss of the barrier
function until the process is well advanced ([24], Beeman
and Neville, unpublished). In a landmark paper Rosen-
blatt [26] and her colleagues showed that isolated apop-
totic cells are extruded from epithelial monolayers by the
formation of an actinomyosin ring in neighboring cells;
this ring gradually tightens around the extruding cell in
such a manner that the neighboring cells maintain their
intercellular contacts. Thus in epithelia the apoptotic
process, called "cellular demolition" by Martin and his
colleagues [27], occurs in a highly controlled fashion,
removing apoptotic cells without a loss of epithelial integ-
rity.
To determine whether changes in the tight junction could
provide a link to extrusion and apoptosis of epithelial
cells, we examined the effects of occludin disruption on
mouse mammary epithelial cell monolayers with fully
formed junctional complexes. We expressed truncated
occludin [15] by transient transfection at low efficiencies.
We also treated the monolayers with a peptide that mim-
ics four amino acids in the second extracellular loop of
occludin [16]. Both agents brought about an increase in
non-junctional occludin that was associated with
increased TUNEL staining, activation of caspases 8 and 3,
Occludin and occludin disrupting molecules Figure 1
Occludin and occludin disrupting molecules. The gen-
eral topology of the tetraspanin molecule occludin and the 
FLAG tagged truncated fragment used to make the truncated 
molecule, F-ΔOcc, are shown in diagrammatic format along 
with the location of an occludin disrupting peptide. COOH, 
C-terminus; PM, plasma membrane; F, FLAG epitope tag; rs, 
restriction site used to make truncated occludin; LYHY, con-
served peptide sequence used in later experiments.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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and extrusion of cells from the monolayer with no
changes in transepithelial resistance (TER). Most intrigu-
ing was our finding of occludin association with the death
inducing signaling complex (DISC) [28], suggesting that
occludin itself may act as a signaling molecule that acti-
vates the extrinsic pathway of programmed cell death.
Results
Expression of dominant-negative occludin using a plasmid 
construct
In an initial experiment we examined the effects of occlu-
din disruption by transiently transfecting CIT3 and Eph4
cells with plasmids expressing a flag-tagged truncated
occludin, F-ΔOcc, as shown in Figure 1. Figure 2A shows
FLAG and ZO1 co-staining of a single transfected CIT3 cell
processed 18 hours after transfection. The FLAG tag was
localized with ZO-1 at the tight junction as well as in
intracellular puncta. The transfected cell is beginning to
round up as is characteristic of the first step in extrusion
[26].
Cells transfected with F-ΔOcc were stained for TUNEL and
the FLAG tag 48 hours post transfection. Control cells
were transfected with bacterial alkaline phosphatase bear-
ing identical FLAG tag and secretory peptide sequences (F-
BAP). Cells that expressed F-BAP maintained normal mor-
phology (Figure 2B, control panel), whereas a variety of
apoptotic morphologies were observed in the F-ΔOcc
transfected cells. At 48 hr, 25% of control-transfected cells
and 60% of F-ΔOcc-transfected cells were TUNEL positive
(Figure 2C). Similar results were obtained with the Eph4
cell line (not shown). Close inspection of the stained cul-
tures showed that the majority of F-ΔOcc-transfected cells
were in various stages of extrusion and/or cellular demo-
lition (Figure 2B&D). In a very occasional view (2B, lower
right) an extrusion stalk could be seen extending apically
from the monolayer. Nuclei in these extruding cells often
were TUNEL negative.
Figure 2D shows an F-ΔOcc-transfected cell rising above
the plane of the epithelium with a condensed but non-
fragmented nucleus. A condensed ring of actin and
myosin is visible at the level of the apical junction com-
plex and below the plane of the nucleus in the extruding
cell, suggesting that the mechanism of extrusion is similar
to that observed by Rosenblatt et al [26]. Note that actin
and myosin are not visible in the surrounding, non-apop-
totic cells. Thus expression of a disrupted form of occludin
in a mammary epithelial monolayer is associated with
apoptosis and extrusion of the transfected cell.
Treatment of polarized epithelial monolayers with an 
occludin disrupting peptide
The next question was whether disruption of occludin by
another means would produce a similar result. We uti-
lized a peptide previously reported to disrupt tight junc-
tions [16]. This peptide contained the LYHY sequence
from the second extracellular loop of mouse occludin cir-
cularized for stability by oxidation of flanking cysteine
residues. To confirm that this peptide disrupted the tight
junction, we performed a "calcium switch" experiment on
filter-grown Eph4 cells with an initial TER of 1000
Ohms•cm2, removing extracellular Ca++and Mg++ to dis-
rupt intercellular junctions. After 15 minutes in the diva-
Plasmid transfection of F-ΔOcc leads to extrusion and apop- tosis Figure 2
Plasmid transfection of F-ΔOcc leads to extrusion 
and apoptosis. A. CIT3 cells on glass slides transiently 
transfected with F-ΔOcc were fixed and stained 18 hr later. 
An antibody to ZO-1 outlines junctional complexes (green) 
and an antibody to FLAG (red) labels a transfected cell. 
Nuclei are stained with DAPI. Yellow in composite images 
represents overlap between ZO-1 and FLAG. B. CIT3 cells 
grown on glass slides were transiently transfected with 
FLAG-bacterial alkaline phosphatase as a control (upper left 
hand panel) or F-ΔOcc. After 48 hr monolayers were fixed 
and stained for TUNEL (red), FLAG (green), and nuclei 
(blue). A spontaneous TUNEL positive nucleus outside two 
F-BAP expressing cells (upper right panel) demonstrates that 
the TUNEL stain is working in this view. C. Transfected cells 
shown in B were identified by their expression of FLAG; the 
proportion of these cells showing TUNEL positivity was 
determined and plotted as a percentage of the FLAG stained 
cells. *** p < .0005. D. Cells transfected with F-ΔOcc as in B 
were visualized by staining for the FLAG epitope, actin, 
myosin, and nuclei as labeled.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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lent cation depleted-medium TER was reduced to zero.
Cells were then switched back to normal medium con-
taining the LYHY or control LYQY peptide (350 μM). The
control peptide (LYQY) has a one amino acid substitution
of the occludin peptide and was similarly circularized.
Peptides were removed after 24 hours. Control peptide-
treated cells recovered the initial TER by 48 hours and the
TER continued to climb, reaching 4000 Ohms￿cm2 (Fig-
ure 3A). The occludin peptide severely retarded TER recov-
ery during the 24 hours it was present in the medium (see
inset), although once removed, the TER began to climb in
parallel with the control.
Treatment of a confluent monolayer of Eph4 cells with
350 μM LYHY peptide for 8 hours (Figure 3B) led to the
appearance of large numbers of cells with irregular non-
junctional occludin distributed in patches. Higher con-
centrations of peptide produced severe disruption of the
monolayer (not shown). Because we were interested in
examining effects on single cells, unless noted, experi-
ments were conducted with 350 μM peptide. Only an
occasional cell showing a non-junctional distribution of
occludin was observed in monolayers treated with the
control peptide. Similar results were obtained with CIT3
and MDCK cells (data not shown). The next question was
whether this disruption of non-junctional occludin led to
apoptosis.
Occludin peptide treatment increased apoptosis in 
polarized epithelial cell monolayers
We treated Eph4 monolayers with the LYHY peptide for
12 hours then examined TUNEL staining by immunohis-
tochemistry (Additional File 1A). Quantitation of TUNEL
stained cells showed that large numbers of apoptotic cells
were present at 4 hours compared to cultures treated with
the control LYQY (Figure 4A). To be sure that occludin
was the target of this reaction, we plated primary cells
derived from the mammary gland of a pregnant occludin
knock-out mouse obtained from M. Furuse [13] and
obtained monolayer cultures. Control cells were obtained
from a wild type female. Both were treated with the LYHY
peptide for 16 hours and stained with an antibody to the
effector caspase 3. Increased apoptosis was observed in
cultures from the wild type but not the occludin-null
mice, providing strong evidence that occludin is necessary
for the apoptotic reaction.
The next question was whether we were dealing with the
extrinsic or intrinsic pathway of apoptosis. Both pathways
utilize an "initiator" caspase to activate the effector cas-
pase, caspase 3; however, both the site of the initial reac-
tion and the initiator caspase differ between the two. In
the intrinsic pathway cell stress or damage leads to release
of cytochrome C from the mitochondria [27]. The cyto-
chrome C seeds a remarkable "apoptosome" assembly
leading to activation of the initiator caspase 9 which in
turn activates caspase 3. The external apoptotic pathway
starts with activation of transmembrane death receptors
such as FAS, TRAIL and others. Activation of these recep-
tors leads to binding of an adaptor protein FADD (Fas-
associated death domain protein), which in turn binds
and aggregates caspase 8, promoting its autoactivation.
Activated caspase 8 in turn cleaves and activates pro-cas-
Effects of an occludin second loop peptide (LYHY) Figure 3
Effects of an occludin second loop peptide (LYHY). A. 
Transepithelial resistance (TER) recovery following the cal-
cium switch. EDTA was applied for 15 minutes to filter 
grown Eph4 monolayers that had achieved a TER of 1000 
Ohms•cm2, reducing the TER to the baseline of 66 
Ohms￿cm2. LYHY or LYQY (350 μM) in growth medium 
containing normal Ca++ and Mg++ was placed above and 
below the filter supports. The TER was measured at 12 and 
24 hours following peptide application (inset). Peptides were 
washed away 24 hrs following application and the TER meas-
ured every 24 hrs thereafter. B. Effect of peptides on occlu-
din distribution in mature Eph4 cell monolayers. EPH4 cells 
on glass slides were treated with 350 μM LYHY or LYQY for 
8 hours then fixed and stained with an anti-occludin antibody. 
Note the frequent areas of non-junctional occludin in the 
LYHY treated cells compared to the control LYQY peptide.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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pase 3 leading to the full apoptotic reaction. We tested the
hypothesis that the pathway activated by the occludin
peptide was the extrinsic pathway in two ways. We first
examined activation of the initiator caspase 8 and the
effector caspase 3, costaining live cells with labeled pep-
tides specific for the active sites of the two caspases. Inter-
estingly slightly more cells reacted with the caspase 8
peptide than the caspase 3 peptide (Figure 4B and Addi-
tional File 1B). Further, cells could be observed with acti-
vated caspase 8 alone but never with activated caspase 3 in
the absence of caspase 8 (Additional File 1B). These
results suggested that LHYH activates the death receptor
pathway and that caspase 8 is the initiating caspase. These
caspases were only slightly activated by the control pep-
tide LYQY (Figure 4B).
To provide a second, more rigorous test of the hypothesis
that caspase 8 is the initiating caspase we measured the
number of cells showing activation of the downstream
effector caspase 3 during inhibition of caspase 8/10 [28].
Mature monolayers were incubated with inhibitors of cas-
pase 8 and 10 (Z-IETD-FMK and Z-AEVD-FMK respec-
tively), no inhibitor, or an inhibitor (Z-LEHD-FMK) of
caspase 9, the initiator caspase of the mitochondrial apop-
totic pathway. Monolayers were then treated with cyclic
LYHY peptide and stained for activated caspase 3 (Figure
5C). The number of cells staining for activated caspase 3
during caspase 8/10 inhibition decreased 75%. Caspase 9
inhibition produced a reduction of 25% or less. Similar
results were obtained when only the caspase 8 inhibitor
(Z-IETD-FMK) was used in this experiment, as expected,
since mouse cells do not express caspase 10 (data not
shown). Our findings provide strong evidence that inter-
nalization of the LYHY peptide with non-junctional
occludin leads to activation of the extrinsic pathway of
apoptosis. With this concentration of peptide cells are
extruded from the monolayer with no loss of epithelial
resistance (Figure 4E).
To examine the mechanism of loss of apoptotic cells, we
applied the LHYH peptide for 6 hours, adding the live cell
probe for activated caspase 8 during the last hour. Careful
microscopic examination revealed occasional caspase 8
LYHY causes apoptosis with no change in TER Figure 4
LYHY causes apoptosis with no change in TER. A. 
Eph4 cells were grown on glass slides and treated with LYHY 
or control LYQY peptide for 4, 8, and 12 hours. Cells were 
TUNEL stained and counted (see Additional File 1A). B. Eph4 
cells were peptide treated and stained live with sulphorhod-
amine-DEVD-fluoromethyl ketone for activated caspase 3 
(C-3) and with carboxyfluorescein-LETD-fluoromethyl 
ketone for caspase 8 (C-8) (see Additional File 1B), fixed, 
photographed and counted. C. Primary cultures from the 
mammary gland of a control mouse and an occludin null 
mouse were treated with the LYHY peptide and stained with 
an antibody for cleaved caspase 3. Control is no peptide. **p 
< 0.01 compared to LHYH treated Occ++ cells, middle bar. 
D. Mature Eph4 monolayers on glass slides were pre-treated 
for 2 hours with a peptide inhibitor of caspase 8/10 or cas-
pase 9, or solvent only (Not inhibited). Cells were then 
treated with LYHY peptide for 2 hours and the number of 
cells showing activated caspase 3 counted. E. Eph4 cells were 
grown on filters until the TER was ~1400 (Ohms￿cm2), then 
treated with solvent, LYHY, or control LYQY peptide at 350 
μM in both top and bottom chambers. Peptides were replen-
ished daily, after recordings. Asterisk indicates a statistically 
significant fall in TER at 72 hours (p < .05) relative to control 
peptide. Results of three wells averaged.
Extrusion of a caspase stained cell after treatment with LYHY Figure 5
Extrusion of a caspase stained cell after treatment 
with LYHY. Mature Eph4 monolayers grown on glass slides 
were treated with LYHY peptide at 350 μM for 6 hours. 
They were stained live during the 6th hour of treatment with 
carboxyfluorescein-LETD-fluoromethyl ketone for activated 
caspase 8 as described in Materials and Methods. After fixa-
tion monolayers were stained for occludin and nuclei. An 
extruding cell stained for caspase 8 shows a narrow extru-
sion "tail" and has a slightly pyknotic nucleus. Surrounding 
cells have closed the gap around the extruding cell as shown 
by occludin staining. Occludin is no longer visible in the 
extruding cell. Black and while images show separate chan-
nels for nuclei, caspase 8 and occludin staining. The merged 
colored image is on the left.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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staining cells being extruded from the monolayer, com-
plete with extrusion stalk (Figure 5) consistent with the
extrusion mechanism shown earlier with F-ΔOcc.
Non-junctional occludin interacts with the Death-Inducing 
Signaling Complex (DISC)
The question now is "What is the pathway by which the
peptide leads to activation of the extrinsic apoptotic path-
way?" We first asked where the LYHY peptide localized by
treating the cell with a FITC-labeled cyclic LYHY peptide.
We found that this peptide did indeed colocalize with
non-junctional occludin (Figure 6A) in contrast to the
control FITC-labeled LYQY peptide, which neither caused
internalization of occludin nor became enriched in
regions of displaced occludin (Figure 6B). E-cadherin dis-
tribution was not changed by the peptide (Figure 6A)
indicating that the adherens junction was not disrupted.
This experiment provides evidence that the LYHY peptide
interacts with occludin, but does not provide information
about the nature of the "occludin patches" or their locali-
zation with respect to the polarity of the epithelial cells.
The next experiments were designed to examine these
issues.
Colocalization of occludin and caspases with components 
of the death receptor pathway
Because we had evidence that treatment with peptide
leads rapidly to apoptosis, we stained Eph4 cells live for
activated caspases 8 and 3 after 30 minutes of treatment
with LHYH. Cells were then fixed and stained with an
antibody to occludin (Figure 7A). An intense patch of acti-
vated caspase 8 substantially colocalized with non-junc-
tional occludin in two adjacent cells. One of these cells
also showed activated caspase 3, colocalized with caspase
8. If occludin and these caspases are localized to the DISC,
components of the death receptor should also be present
in these regions. In fact, immunostaining showed that Fas
and FADD are localized to the same regions as non-junc-
tional occludin and caspase 8 (Figure 7B &7C). Thus the
DISC appears to contain Fas, FADD, and caspases 3 and 8
and occludin, suggesting death receptor activation by
non-junctional occludin.
If occludin forms a true complex with the disc we should
be able to immunoprecipitate it with FADD, a component
of the DISC. In Figure 8A a band corresponding to occlu-
din can be seen after immunoprecipitation of FADD from
LYHY treated cells. This figure also shows that the propor-
tion of occludin that can be immunoprecipitated is small
and somewhat variable, Figure 8B. Similar results were
obtained in 3 independent experiments.
Localization of the DISC aggregate
The next question is how the localization of the DISC
relates to the polarity of the cell. Using digital confocal
microscopy we examined a Z-stack of images from the
apex to the basal surface of the cell. To mark the apical sur-
face cells were co-stained with an antibody to MUC1, a
mucin localized exclusively to the apical surface of the cell
(Figure 9). The middle images show the XY plane. The ZX
plane was calculated at two different positions of Y, as
shown by the white lines in the middle left image, and the
ZX images are depicted above and below the XY images.
In these images activated caspase 8 appeared to be local-
ized just basal to MUC1 and the main body of occludin
staining. However, there is a fuzzy projection of occludin
into the region of caspase 8 staining as shown by the yel-
low band separating the red occludin and green caspase 8
bands in the lower left hand image. Thus the DISC is
located apically and the occludin associated with the
DISC appears to be in the membrane suggesting that
occludin moves through the membrane to activate the
death receptor.
Peptide localization in EPH4 cells Figure 6
Peptide localization in EPH4 cells. EPH4 cells grown on 
glass slides were treated with FITC labeled LYHY (A) or 
LYQY (B) peptides (350 μM) for 6 hr (pseudocolored red). 
After fixation, cells were stained with antibodies against 
occludin (green pseudocolor) and E-cadherin (green pseudo-
color) and with DAPI for nuclei (blue). LYHY accumulated in 
regions enriched in non-junctional occludin, denoted by 
arrowhead. LYQY did not alter occludin distribution 
although it appeared to localize in the cytoplasm of some 
cells. E-cadherin distribution was not altered by LYHY.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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Discussion
To examine the potential role of tight junction disruption
in the controlled demolition of the epithelial cell, we used
two previously published occludin-disrupting tools in
three epithelial cell lines (Eph4, CIT3, and MDCK) as well
as primary cultures of the mammary epithelium. We
found that both a truncated occludin construct and a pep-
tide identical to 4 amino acids in the second extracellular
loop of occludin increased non-junctional occludin,
increased activation of caspases 8 and 3, and brought
about TUNEL staining in treated cells. Cells with these
signs of apoptosis were extruded from the monolayer with
no change in TER. There was no increased apoptosis in
occludin null cells exposed to the peptide. At early times
non-junctional occludin was localized in the DISC with
activated caspases 8 and 3 as well as with the death recep-
tor FAS protein and the adaptor protein FADD. It could be
co-immunoprecipitated with FADD. These findings sug-
gest that disruption of occludin leads to its displacement
from the tight junction to the DISC, initiating extrusion
and apoptosis of the affected cell by the Type I extrinsic
pathway [29].
Expression of truncated occludin
The F-ΔOcc construct had been previously used as a dom-
inant negative occludin to transfect cultured salivary cells
[15]. These cells showed normal distribution of endog-
enous occludin, ZO-1, and JAM. However, tracer flux was
increased and TER decreased. This experiment differed
from ours in that the salivary cells were stably transfected
and constitutively expressing, surviving cells were
Localization of caspase 8 with displaced occludin and DISC  proteins after LYHY treatment of Eph4 monolayers on glass  slides Figure 7
Localization of caspase 8 with displaced occludin and 
DISC proteins after LYHY treatment of Eph4 monol-
ayers on glass slides. A. Cells were treated with LYHY at 
350 μM for 30 minutes and stained live during peptide treat-
ment for activated caspase 8 (green, A1, 2) and activated cas-
pase 3 (Red, A2). Cells were then fixed and stained for 
occludin (red pseudocolor, A1) and nuclei (Blue). Activated 
caspase 3 co-localizes with disrupted occludin and with acti-
vated caspase 8 in the right hand cell only. B. EPH4 cells on 
glass slides were treated for 2 hr with LYHY then stained live 
for activated caspase 8 (green B1, B2). After fixation monol-
ayers were stained for occludin (pseudocolored red, B1), the 
DISC adapter protein FADD (red, B2) and nuclei (blue). The 
smaller panel under B5 shows an image that has been 
exposed for a longer time, and suggests that FADD is 
present at lower intensity in regions free of non-junctional 
occludin. C. EPH4 cells were treated with LYHY and stained 
for activated caspase 8 (green C1, C2; C4) and occludin as 
well as the death receptor Fas (red, C1 and white C5), and 
nuclei (blue). The smaller panel under C5 shows a more 
highly contrasted view of the region within the white box of 
the Fas panel. Like FADD, low levels of Fas appear to be 
present in cellular regions free of non-junctional occludin.
Co-immunoprecipitation of occludin with FADD after treat- ment with LYHY Figure 8
Co-immunoprecipitation of occludin with FADD 
after treatment with LYHY. Eph4 cells were treated with 
800 μM LHYH for 5 hrs or left untreated after medium 
change. Cells were lysed and proteins immunoprecipitated 
with a mouse anti-FADD antibody using protein A/G agarose 
beads and blotted with a rabbit anti-occludin antibody. A. 
Western blot for occludin. Lysates of cells that were immu-
noprecipitated with an anti-FADD antibody. IP-FADD: Two 
left lanes show IP of lysates from untreated EPH4 cultures 
and two right hand lanes show IP of lysates from LYHY 
treated EPH4 cultures. A very small proportion of the total 
cellular occludin was associated with FADD. B. Quantitation 
of occludin bands from 3 control and treated cultures. The 
intensity of stain was variable but higher in the immunopre-
cipitated fractions from LHYH treated cells (P < 0.1). Similar 
results were obtained from 2 comparable experiments.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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selected. We used low concentrations of plasmid to obtain
transient transfection of sparsely located cells, which then
underwent apoptosis and left the monolayer. It would be
of considerable interest to determine how the stably trans-
fected monolayers were able to adapt to expression of the
mutant construct.
Peptides mimicking other occludin sequences
Tight junction disruption via peptides containing
sequences in the second extracellular loop of occludin has
been previously reported [17,18,30,31]. When intact
EPH4 cell monolayers were treated with a 44 amino acid
peptide comprising the entire second extracellular loop of
chicken occludin, isolated patches of cells throughout the
monolayer showed a punctate, intracellular, non-junc-
tional distribution of occludin [31]. These peptide-treated
cells maintained a TER above 3000 Ohms·cm2, about
50% of that of controls. In another laboratory a peptide
mimicking a 22 amino acid sequence in the second extra-
cellular loop impeded recovery of TER and caused inter-
nalization of several tight junction transmembrane
proteins following the calcium switch in human intestinal
epithelial cells [17]. Similar results were obtained with a
rat 19 amino acid second extracellular loop mimic in a rat
Sertoli cell line [30]. In these latter two studies the peptide
ended two amino acids upstream of the LYHY sequence
suggesting that regions comprising peptides other than
LYHY are also involved in homophilic interactions of
occludin.
Extrusion and TER
The finding that a large increase in apoptosis, which
occurred in all studies, did not decrease the trans-epithe-
lial resistance suggests that loss of single epithelial cells
proceeds by an orderly biological process that maintains
rather than disrupts the epithelial barrier. Similarly, cul-
tured monolayers of intestinal epithelial cells were able to
maintain 50% of basal TER when treated with a Fas
crosslinking antibody that led to the loss of half of the
cells in the culture in only 24 hours [23]. Because we
observed an actomyosin "purse string" around extruding
cells in our study (Figure 2D), the mechanism of extrusion
first elucidated by Rosenblatt and colleagues [26] is likely
used.
Is displaced junctional occludin acting as a signaling 
molecule?
It has been known for some time that viral and bacterial
pathogens can enter cells utilizing occludin and other ele-
ments of the tight junction [1-6,8]. In fact, Greber and
Gustaldelli [3] have called the tight junction the "Achille's
heel of epithelial cells in pathogen infection". Our studies
raise the very important question of whether signaling
through disrupted occludin could provide a significant
host defense against, at least moderate concentrations of,
pathogens by producing controlled extrusion and apopto-
sis of affected cells. A recent study of the induction of epi-
thelial cell apoptosis by enteropathogenic E. coli (EPEC) is
consistent with such a mechanism [6]. EPEC infection led
to the cleavage of occludin and ZO-1 and the mis-locali-
zation of these molecules. Subsequently an increase in
apoptosis markers was observed. We only observed full
length occludin in FADD pulldowns, suggesting that the
peptide in some way releases full length occludin from the
tight junction freeing it to interact with apical membrane
FAS and FADD prior to any cleavage. This reaction con-
trasts with the finding that occludin prevents apoptosis in
cultures of hepatic cells [12]. It is possible that occludin
can both stabilize junctional complexes and signal to a
cell that its junctional complex has been perturbed by a
pathogenic agent. If so, occludin is quite a versatile mole-
cule.
Schneeberger has previously suggested that occludin
might serve as a signaling molecule, although in a differ-
ent context [20]. While the results of our studies are con-
sistent with a role for non-junctional occludin as a
signaling molecule, it is clear that many other signaling
molecules are also associated with tight junctions [3]. Any
one of a number of these could transmit a signal from a
disrupted tight junction to the extrinsic apoptotic path-
way. An intriguing possibility is that the Akt antagonist,
lipid phosphatase PTEN (phosphatase and tensin
homolog deleted from chromosome 10) links loss of
occludin function to apoptosis. Several reports have dem-
onstrated that the PTEN binds to the tight junction asso-
ciated MAGI-2 [32], PAR [33,34], and DLG [32] proteins
and PTEN binding to the PDZ domain of Magi-2 pro-
moted its stability [35]. Moreover, PTEN plays a role in
activation of the death receptor pathway of apoptosis
under various conditions [36-38]. Our preliminary results
Cellular localization of activated caspase 8 and non-junctional  occludin Figure 9
Cellular localization of activated caspase 8 and non-
junctional occludin. Cells were grown and stained as in 
Figure 7A except that the apical plasma membrane marker 
MUC1 (red, third panel, white 4th panel) was stained in place 
of caspase 3. Two sets of white lines in the first panel show 
the plane of two slightly different digital XZ-sections pro-
jected above and below the central XY image in this compos-
ite image.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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show that PTEN is associated with the tight junction in
Eph4 cells (data not shown). It will be of interest to deter-
mine whether it plays a role in linking occludin disrup-
tion to death receptor mediated apoptosis.
Future directions
The results of our experiments link disruption of the tight
junction protein occludin to stimulation of apoptosis via
the extrinsic pathway and provide a potential defense
mechanism for ridding the epithelium of cells exposed to
pathogens. They also raise questions for further experi-
mentation: For example, does the apoptotic process
involved meet criteria for Type I death receptor activation
other than the recruitment of large amounts of caspase 8
to the DISC [29]? Interestingly, Nusrat and her colleagues
have proposed that the tight junctional components
reside in lipid raft-like complexes [39]. The diffuse nature
of the occludin stain in Figures 6, 7 and 9 leads us to ask
whether portions of these rafts might detach from the
junction and fuse with the DISC, which has also been
shown to localize to lipid rafts [40].
Conclusion
We have found that a small cyclized peptide LYHY dis-
rupts occludin localization at the tight junction and acti-
vates the extrinsic pathway of programmed cell death. At
early times occludin is localized at the death inducing sig-
naling complex and can be immunoprecipitated with
FADD, a member of this complex. These observations sug-
gest that occludin has a protective as well as a barrier
forming role in epithelia; pathogenic agents which utilize
this protein as an entry point into the cell might set off an
apoptotic reaction allowing extrusion of the infected cell
before the pathogen can gain entry to the interstitial space.
Methods
Antibodies
Anti occludin, Zymed® clone OCOC-3F10; anti Fas, BD
Biosciences clone 13; anti ZO-1, Chemicon® MAB1520;
anti FADD, USBiological clone 12E7; anti MUC1, Abcam
inc. clone EP1024Y; anti-caspase 3, Cell Signaling Tech-
nology® (8G10); anti-caspase 8, Axxora® (1G12).
Mice
A breeding colony of occludin null homozygous mice is
maintained in our animal facility. To derive occludin-null
cells male and female hemizygotes are cross-bred and
female homozygotes are selected and bred. These mice
can lactate, although lactation performance is inconsist-
ent (Monks, Webb and Neville, unpublished). For the cur-
rent experiments, mice whose pregnancies were timed by
the appearance of a vaginal plug, were sacrificed at day 15
of pregnancy and the 4th and 5th mammary glands excised
and collagenase treated as described previously to obtain
isolated epithelial organoids [41]. These organoids are
plated on FBS treated Lab Tek II, CC2 glass chamber slides
(Nunc) where they form nearly confluent monolayers
with well formed junctions as indicated by ZO1 staining
within 3 to 6 days of culture (Wilson and Neville, data not
shown). Organoids from wild type mice are handled sim-
ilarly. These procedures have been approved by the Insti-
tutional Animal Care and Use Committee of the Anschutz
Medical Campus of the University of Colorado Denver.
Cells and Cell culture
EpH4 mammary epithelial cells [42] were grown in
DMEM (GibcoBRL, Grand Island, NY) with 10 mM
HEPES (Sigma-Aldrich) and subcultured every 3-4 days
[41]. CIT3 mouse mammary epithelial cells were grown as
described [43] in DMEM with Ham's F12 (50:50) supple-
mented with 2% heat-inactivated fetal bovine serum
(FBS), 5 ng/ml epidermal growth factor (EGF), 10 mg/ml
insulin, 100 U/ml penicillin and 100 mg/ml streptomy-
cin. To differentiate CIT3 cells, the growth medium was
modified by removal of EGF and addition of 3 mg/ml
each of ovine prolactin (National Hormone and Pituitary
Program, Rockville, MD) and hydrocortisone (Sigma
Chemical Co. St. Louis, MO). MDCK cells were grown in
MEM with 2 mM L-glutamine and Earle's BSS adjusted to
contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essen-
tial amino acids, 1.0 mM sodium pyruvate, and 10% FBS
[44]. Cultures were maintained at 37°C in 5% CO2 in air.
For primary cultures mammary epithelial cells from 15
day pregnant mice were isolated as described above.
For immunohistochemistry and measurement of transep-
ithelial resistance, cells were trypsinized from polycar-
bonate flasks, plated at 1:2 and grown for 7 days, then
plated at 2× confluent density on FBS treated Lab Tek II,
CC2 glass chamber slides (Nunc) or Transwell® filters
(Product #3413) as stated in figure legends. Cells were
grown 3 days then, for CIT3 cells, switched to medium
containing hormones for 2 days prior to the beginning of
experiments.
Expression constructs and transient transfection
Mouse occludin ATCC #MGC-5797 was cut with BsaA1 in
the second extracellular loop and Bcl1 in the 5' UTR and
inserted in pFLAG-CMV-1 (Sigma-Aldrich), placing it
downstream of a secretory signal peptide and N-terminal
FLAG epitope tag (F-ΔOcc). As a control vector pFLAG-
CMV-1-BAP, which encodes secretory, N-terminal FLAG
tagged, bacterial alkaline phosphatase, was obtained from
Sigma-Alrich. F-ΔOcc or pFLAG-CMV-1-BAP was trans-
fected into cells using FuGENE® HD (Roche) according to
the manufacturer's instructions. Cells were plated in the
morning at confluent density, transfected in the evening,
and transfection medium was replaced with differentia-
tion medium the following morning.BMC Cell Biology 2009, 10:85 http://www.biomedcentral.com/1471-2121/10/85
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Peptide synthesis
Synthesis of linear CLYHYC was accomplished using
Fmoc chemistry. Assembly of side-chain protected N-α-
Fmoc amino acids (AAs) was carried out on a resin sup-
port. Acylation reactions were carried out for 2 hours
using 3-fold excess of Fmoc-AAs activated with N, N'-
diisopropylcarbodiimide (DIC) in the presence of N-
hydroxybenzotriazole (HOBt). The N-terminal Fmoc
group was removed with 20% piperidine in N,N-dimeth-
ylformamide. Linear peptide was cleaved from the fully
dried peptide-bound resin with freshly prepared TFA solu-
tion (TFA 94%, water 2.5%, ethanedithiol 2.5%, triiso-
propylsilane 1%) for 2.5 hours under nitrogen
atmosphere and then cyclized with 5% iodine in metha-
nol and purified to 95% pure cyclic H-CLYHYC-OH by
reverse phase HPLC. Peptide mass was confirmed by
MALDI-TOF mass spectrometry (expected [M+H]+ 799.9,
found 799.8). Cyclic H-CLYQYC-OH was made using the
same process except that H was replaced by Q. Peptide
mass was confirmed by mass spectrometry (expected
[M+H]+ 790.9, found 790.6).
Activated caspase stains
Cells were live stained with Image-iT®LIVE Green Caspase
8 Detection Kit (Molecular Probes) and/or Image-iT®LIVE
Red Caspase 3 and 7 Detection Kit (Molecular Probes).
Stains were diluted into differentiation medium contain-
ing LYHY or LYQY. After 1 hr at 37° cells were rinsed in
4°C differentiation medium, and processed for immun-
ofluorescence.
Caspase 9 and caspase 8/10 inhibition
Caspase 9 inhibitor (Z-LEHD-FMK Cat.#FMK008), 100
μM, caspase 8 inhibitor (Z-IETD-FMK Cat.#FMK007), 50
μM, or caspase 10 inhibitor (Z-AEVD-FMK Cat.#FMK009)
(R&D systems), 50 μM, was dissolved in medium and
incubated with cells for 2 h. LYHY peptide was then
applied at 350 μM with inhibitors for 2 hours total. Cas-
pase 3 staining was performed during the last hour of
LYHY treatment as described above.
Immunofluorescence
Cells were fixed in 2% paraformaldehyde, then permeabi-
lized and blocked in 3% BSA in 0.1% Triton X-100 TBS.
Antibodies were diluted into this solution and incubated
with cells overnight at 4°C. In all cases secondary anti-
bodies were goat anti host IgG, highly cross-absorbed,
with appropriate fluors obtained from Molecular Probes.
TUNEL Staining
TUNEL staining was performed using the Roche In Situ
Cell Death Detection Kit, TMR red. Cells were fixed in 2%
paraformaldehyde and permeabilized in 1% sodium cit-
rate (tri-sodium salt) containing 0.1% TX-100. Staining
was performed as per manufacturer's instructions.
Fluorescence imaging
Images were collected, processed and analyzed using
SlideBook software (Intelligent Imaging Innovations,
Inc.) on a Nikon Diaphot TMD microscope equipped for
fluorescence with a Xenon lamp and filter wheels (Sutter
Instruments), fluorescent filters (Chroma), cooled CCD
camera (Cooke) and stepper motor (Intelligent Imaging
Innovations, Inc.). Adjacent z-sections were collected and
deconvolved using a nearest neighbor algorithm. Multi-
fluor images were merged and renormalized.
Immunoprecipitation
Cells were washed with ice cold PBS before 0.5 ml of lysis
buffer (30 mM Tris HCl pH 7.4, 150 mM NaCl, 1% Triton
X-100, 10% glycerol, 2 mM EDTA, 5.7 μl/ml 100 mM
PMSF, 20 μl/ml Roche Complete EDTA-Free Inhibitor
Cocktail, and 1 μl/ml 1 M DTT) was added to the culture
plate. Cells were scraped from the plate and placed in a
microfuge tube. Cells in lysis buffer were constantly agi-
tated for 20 minutes at room temperature and then spun
at 13, 900 rpm for 20 minutes. The supernatant was col-
lected in a fresh tube and stored at 4°C.
Lysates containing 500 μg protein were incubated with 10
μg mouse anti-FADD (BD Biosciences) antibody for 2.5
hours at room temperature. Protein A/G Agarose beads
(20 μl, Santa Cruz) were added to the lysate/antibody
mixture for 1 hour before being washed 3 times in lysis
buffer, followed by a wash in high salt lysis buffer (regular
lysis buffer with 500 mM NaCl), followed by a final wash
in regular lysis buffer. Bead/antibody/FADD complex was
resuspended in 50 μl 2 × Llaemmili buffer and boiled for
5 minutes. The sample was then spun at 2, 500 rpm for 5
minutes and the supernatant was collected in a fresh tube
and stored at 4°C. Samples (30 μg original cell lysate, 25
μl IP product) were loaded on a 12% acrylamide gel and
run at 100 Volts for about 1.5 hours. The gel was trans-
ferred onto PVDF and treated with rabbit anti-occludin
antibody (1:2000, Santa Cruz) at 4°C overnight. The
membrane was then treated with a donkey anti-rabbit
IgG, Horseradish Peroxidase linked antibody (GE Health-
care).
Abbreviations
Ad-F-ΔOcc; N-terminally FLAG tagged: N-terminally trun-
cated mouse occludin mutant; BAP: bacterial alkaline
phosphatase; DISC: Death inducing signaling complex;
EPEC: enteropathogenic Escherichia coli; GFP: green fluo-
rescent protein; TER: transepithelial resistance; TUNEL:
Terminal deoxynucleotidyl transferase dUTP nick end
labeling.
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